FR2357254A1 - Preparation pharmaceutique pour le traitement de l'osteoporose et procede pour la fabriquer - Google Patents
Preparation pharmaceutique pour le traitement de l'osteoporose et procede pour la fabriquerInfo
- Publication number
- FR2357254A1 FR2357254A1 FR7720612A FR7720612A FR2357254A1 FR 2357254 A1 FR2357254 A1 FR 2357254A1 FR 7720612 A FR7720612 A FR 7720612A FR 7720612 A FR7720612 A FR 7720612A FR 2357254 A1 FR2357254 A1 FR 2357254A1
- Authority
- FR
- France
- Prior art keywords
- compsn
- ascorbic acid
- pref
- delayed
- prolonged release
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/16—Fluorine compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/0216—Solid or semisolid forms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/20—Halogens; Compounds thereof
- A61K8/21—Fluorides; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/676—Ascorbic acid, i.e. vitamin C
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Birds (AREA)
- Inorganic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
L'invention concerne une préparation pharmaceutique pour le traitement de l'ostéoporose. Ladite préparation contient comme agents actifs : a. Un fluorure (sel) soluble (NaF, KF); et b. De l'acide ascorbique -L et /ou de sels alcalins ou alcalino-terreux de cet acide Les constituants a et b sont utilisés dans un rapport molaire de 1 : 0,5 à 1 : 5,0. La préparation est présentée de préférence sous forme d'un composé à action retardée en deux étapes. Application à l'abaissement de la dose de fluorure à une valeur ne provoquant pas de douleurs périostales.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19762630326 DE2630326C2 (de) | 1976-07-06 | 1976-07-06 | Präparat zur Behandlung der Osteoporose und seine Herstellung |
Publications (2)
Publication Number | Publication Date |
---|---|
FR2357254A1 true FR2357254A1 (fr) | 1978-02-03 |
FR2357254B1 FR2357254B1 (fr) | 1981-09-11 |
Family
ID=5982328
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR7720612A Granted FR2357254A1 (fr) | 1976-07-06 | 1977-07-05 | Preparation pharmaceutique pour le traitement de l'osteoporose et procede pour la fabriquer |
Country Status (4)
Country | Link |
---|---|
AT (1) | AT364716B (fr) |
BE (1) | BE856458A (fr) |
DE (1) | DE2630326C2 (fr) |
FR (1) | FR2357254A1 (fr) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2604360A1 (fr) * | 1986-09-25 | 1988-04-01 | Colgate Palmolive Co | Medicament a liberation controlee pour fournir des ions fluorure |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3343253A1 (de) * | 1983-08-11 | 1985-02-21 | Neill Bailey San Antonio Tex. Walsdorf | Fluorid-tablette mit verzoegerter wirkstoff-freigabe und verfahren zu ihrer herstellung |
US5013728A (en) * | 1990-05-04 | 1991-05-07 | Colgate - Palmolive Company | Composition for treating osteoporosis and hormonal imbalance |
-
1976
- 1976-07-06 DE DE19762630326 patent/DE2630326C2/de not_active Expired
-
1977
- 1977-07-04 BE BE179068A patent/BE856458A/fr not_active IP Right Cessation
- 1977-07-05 FR FR7720612A patent/FR2357254A1/fr active Granted
- 1977-07-06 AT AT0485577A patent/AT364716B/de not_active IP Right Cessation
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2604360A1 (fr) * | 1986-09-25 | 1988-04-01 | Colgate Palmolive Co | Medicament a liberation controlee pour fournir des ions fluorure |
NL8702297A (nl) * | 1986-09-25 | 1988-04-18 | Colgate Palmolive Co | Medicament voor het verschaffen van fluoride-ionen voor de behandeling en preventie van met botverlies gepaardgaande ziekten. |
BE1000159A5 (fr) * | 1986-09-25 | 1988-06-28 | Colgate Palmolive Co | Medicament a liberation controlee pour fournir des ions fluorure. |
Also Published As
Publication number | Publication date |
---|---|
BE856458A (fr) | 1977-10-31 |
FR2357254B1 (fr) | 1981-09-11 |
AT364716B (de) | 1981-11-10 |
ATA485577A (de) | 1981-04-15 |
DE2630326C2 (de) | 1983-07-21 |
DE2630326A1 (de) | 1978-01-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MXPA02011942A (es) | Composiciones, equipos y metodos para estimular beneficios definidos para la salud. | |
Neuman et al. | Synthetic hydroxyapatite crystals: IV. Magnesium incorporation | |
ES8502873A1 (es) | Metodo de preparacion de soluciones para dialisis. | |
AU3981089A (en) | Salt product and method for its preparation | |
LTIP1472A (en) | Composition of priming hard tissue of tooth | |
KR870008580A (ko) | 항치석 치약 | |
JPS6333321A (ja) | 口腔組成物 | |
IL75536A0 (en) | Pseudomonic acid salt,its preparation and pharmaceutical and veterinary compositions comprising it | |
MY101750A (en) | Improvements in or relating to calcium salts. | |
EA200001191A1 (ru) | Новые фармацевтические композиции для лечения и жизнеобеспечения (поддержания жизненных функций) и способ их приготовления | |
ES510245A0 (es) | "un metodo para obtener una preparacion de insulina". | |
FR2357254A1 (fr) | Preparation pharmaceutique pour le traitement de l'osteoporose et procede pour la fabriquer | |
ES472847A1 (es) | Procedimiento para la preparacion de la 2-bromoergosina y sus sales acidas de adicion | |
GB2272375A (en) | Pharmaceutical composition | |
ES364982A1 (es) | Un procedimiento para la elaboracion de un preparado de hierro oral. | |
AU2908189A (en) | Aqueous preparation based on mineral salts and acetic acid for the prevention and treatment of viral diseases | |
IL41412A (en) | Mineral salt preparation | |
CA2001123A1 (fr) | Traitement de l'osteoporose | |
GB1501096A (en) | Methods and pharmaceutical preparation for the treatment of hypercholesterolaemia | |
SE7602359L (sv) | Aluminiumpolyhydroxisulfat-hydrat | |
JPS63141921A (ja) | 口腔用組成物 | |
GB1221633A (en) | Compositions for hardening teeth and bones | |
RU2002116377A (ru) | Жидкие лечебные составы для внутривенного введения, содержащие декстрозу и инсулин | |
HU213872B (en) | Oligo- and polygalacturonate mixed complex, pharmaceutical and food compositions containing them, further process for preparing these compounds | |
DE3362246D1 (en) | Magnesium salt of chenodeoxycholic acid and ursodeoxycholic acid, the process for its preparation, and therapeutic compositions which contain it as active principle |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
ST | Notification of lapse |